Delayed onset eruptive keratoacanthomas following immune checkpoint inhibitor therapy
- 11 September 2024
- journal article
- research article
- Published by Wiley in International Journal of Dermatology
- Vol. 64 (5) , 915-917
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- To treat or not to treat: PD-L1 inhibitor-induced keratoacanthoma and squamous cell carcinomaArchives of Dermatological Research, 2022
- A guide to cancer immunotherapy: from T cell basic science to clinical practiceNature Reviews Immunology, 2020
- Hypertrophic Lichen Planus with Histological Features of Squamous Cell Carcinoma Associated with Immune Checkpoint Blockade TherapyThe Oncologist, 2020
- Timing of Onset of Adverse Cutaneous Reactions Associated With Programmed Cell Death Protein 1 Inhibitor TherapyJAMA Dermatology, 2018
- Eruptive keratoacanthomas secondary to nivolumab immunotherapyInternational Journal of Dermatology, 2018